Notes:

https://pubs.acs.org/doi/full/10.1021/ci8002649

target	mode of interaction	target class	prim. assay (AID)	confirm. assay (AID)	assay-type	Hill slope	PA	PD
S1P1 rec.	agonists	GPCR	449	466	reporter gene	PubChem	223a	55395
PKA	inhibitors	kinase	524	548	enzyme	PubChem	62	64814
SF1	inhibitors	nuclear receptor	525	600	reporter gene	PubChem	213	64550
Rho-Kinase2	inhibitors	kinase	604	644	enzyme	PubChem	67	59576
HIV RT-RNase	inhibitors	RNase	565	652	enzyme	PubChem	370	63969
Eph rec. A4	inhibitors	rec. tyr. kinase	689	689b	enzyme	PubChem	80	61480
SF1	agonists	nuclear receptor	522	692	reporter gene	PubChem	75	63683
HSP 90	inhibitors	chaperone	429	712	enzyme	calculated	91	63481
ER-a-coact. bind.	inhibitors	PPIc	629	713	enzyme	calculated	221	84656
ER-Î²-coact. bind.	inhibitors	PPIc	633	733	enzyme	calculated	194	84984
ER-a-coact. bind.	potentiators	PPIc	639	737	enzyme	not applicabled	64	84947
FAK	inhibitors	kinase	727	810	enzyme	PubChem	110	96070
Cathepsin G	inhibitors	protease	581	832	enzyme	PubChem	65	62007
FXIa	inhibitors	protease	798	846	enzyme	PubChem	70	218421
S1P2 rec.	inhibitors	GPCR	736	851	reporter gene	PubChem	54	96674
FXIIa	inhibitors	protease	800	852	enzyme	PubChem	99	216795
D1 rec.	allosteric modulators	GPCR	641	858	reporter gene	PubChem	226	54292
M1 rec.	allosteric inhibitors	GPCR	628	859	reporter gene	PubChem	231	61477